Last Price
2.22
Today's Change
-0.05 (2.20%)
Day's Change
2.02 - 2.28
Trading Volume
157,636
Market Cap
76 Million
Shares Outstanding
34 Million
Avg Volume
231,414
Avg Price (50 Days)
2.80
Avg Price (200 Days)
5.96
PE Ratio
-4.11
EPS
-0.54
Earnings Announcement
26-Feb-2025
Previous Close
2.27
Open
2.20
Day's Range
2.0203 - 2.2821
Year Range
1.078 - 46.0
Trading Volume
157,636
1 Day Change
-2.20%
5 Day Change
-10.12%
1 Month Change
-21.00%
3 Month Change
-31.90%
6 Month Change
-68.78%
Ytd Change
-92.37%
1 Year Change
-92.37%
3 Year Change
-92.37%
5 Year Change
-92.37%
10 Year Change
-92.37%
Max Change
-92.37%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
FibroBiologics, Inc., a clinical-stage cell therapy company, develops and commercializes fibroblast-based therapies in the United States. It is developing CybroCell, for the treatment of degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for wound healing. The company is also on the early-stage research of CYTER915, which is designed to regenerate or reinvigorate production of the thymus and/or spleen; CYPS317, for the treatment of psoriasis; and TCB190 to treat certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.